Simultaneous determination of venlafaxine and its main active metabolite O-desmethyl venlafaxine in rat plasma by LC-MS/MS

Analytical Sciences

Volumn 25, Issue 10, 2009, Pages 1207-1210

  Shah, Gaurang R ^a   Thaker, Bharat T ^a   Surati, Kiran R ^b   Parabia, Minu H ^a  

^a VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^b SARDAR PATEL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLITES; RATS;

COEFFICIENT OF DETERMINATION; COEFFICIENTS OF VARIATIONS; LIQUID-LIQUID EXTRACTION; LOWER LIMIT OF QUANTIFICATIONS; O-DESMETHYL VENLAFAXINE; SELECTIVE LIQUID CHROMATOGRAPHY; SIMULTANEOUS DETERMINATIONS; TERT-BUTYL METHYL ETHERS;

DRUG PRODUCTS;

EID: 72249103633     PISSN: 09106340     EISSN: 13482246     Source Type: Journal    
DOI: 10.2116/analsci.25.1207     Document Type: Article

References (28)

1. Duvermeuil, Ther. Drug. Monit., 2003, 25, 565.
2. E. Muth, J. Haskin, J. Moyer, G. M Husbands, S. Nielson, and E. Sigg, Biochem. Pharmacol., 1986, 35, 4493.
3. M. Matoga, F. Pehourcq, K. Titier, F. Dumora, and C. Jarry, J. Chromatogr., B, 2001, 760, 213.
4. V.P. Leung, H.F. Chiu., and L.C. Lam, Pharmacopsychiatry, 1998, 31, 32.
5. B. Skop, T. Rocha, V. Morsch, R. Neis, and M. Schetinger, Biochim. Biophys. Acta, 2002, 1587, 92.
6. E. Lacassie, J. Gaulier, P. Marquet, J. Rabatel, and G. Lachatre, J. Chromatogr., B, 2000, 742, 17.
7. J. Bhatt, A. Jangid, G. Venkates, G. Subaiah, and S. Singh, J. Chromatogr., B, 2005, 829, 75.
8. A. Castro, M. Concheiro, O. Quintela, A. Cruz, and M. López-Rivadulla, J. Pharm. Biomed. Anal., 2008, 48, 183.
9. B. Patel, N. Sharma, M. Sanyal, and P. Shrivastav, J. Pharm. Biomed. Anal., 2008, 47, 603.
10. N. Castaing, K. Titier, M. Receveur-Daurel, M. Le-Déodic, D. Le-Bars, N. Moore, and M. Molimard, J. Anal. Toxicol., 2007, 31, 334.
11. Z. Wei, X. Bing-Ren, and W. Cai-Yun, Biomed. Chromatogr., 2007, 21, 266.
12. W. Smyth, J. Leslie, S. McClean, B. Hannigan, H. McKenna, B. Doherty, C. Joyce, and E. O'Kane, Rapid Commun. Mass Spectrom., 2006, 20, 1637.
13. P. Cutroneo, M. Beljean, R. Luu, and A. Siouffi, J. Pharm. Biomed. Anal., 2006, 41, 333.
14. K. Titier, N. Castaing, E. Scotto-Gomez, F. Pehourcq, N. Moore, and M. Molimard, Therap. Drug Monit., 2003, 25, 581.
15. C. Duverneuil, G. Grandmaison, P. Mazancourt, and J. Alvarez, Therap. Drug Monit., 2003, 25, 565.
16. B. Raut, B. Kolte, A. Deo, M. Bagool, and D. Shinde, J. Liq. Chromatogr. Relat. Technol., 2003, 26, 1297.
17. K. Goeringer, I. McIntyre, and O. Drummer, J. Anal. Toxicol., 2003, 27, 30.
18. G. Tournel, N. Houdret, V. Hédouin, M. Deveaux, D. Gosset, and M. Lhermitte, J. Chromatogr., B, 2001, 761, 147.
19. J. Bickeboeller-Friedrich and H. Maurer, Therap. Drug Monit., 2001, 23, 61.
20. L. Labat, M. Deveaux, P. Dallet, and J. Dubost, J. Chromatogr., B, 2002, 773, 229.
21. P. Shah, K. Midha, W. Findlay, M. Hill, D. Hulse, J. Mcgilveray, G. Mckay, J. Miller, N. Patnaik, L. Powell, A. Tonelli, C. Viswanathan, and A. Yacobi, Pharm. Res., 2000, 17, 1551.
22. N. Nagaraja, J. Paliwal, and R. Gupta, J. Pharm. Biomed. Anal., 1999, 20, 433.
23. D. Dadgar and P. Burnett, J. Pharm. Biomed. Anal., 1995, 14, 23.
24. R. Causon, J. Chromatogr., B, 1997, 689, 175.
25. F. Bressolle, M. Bromet-pitit, and M. Audran, J. Chromatogr., B, 1996, 686, 3.
26. Anonymous, May 2001, Guide for Industry, Bioanalytical Method Validation, 2001, U.S. Department of Health and Human Services, Food and Drug Administration (FDA).
27. F. Bressolle, M. Bromet-Petit, and M. Audran, J. Chromatogr., B, 1996, 686, 3.
28. Guidance for Industry, Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues, Draft Guidance, 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Washington, D.C. Analyte.